Triazolopyrazines and methods of making and using the same
US7674791B2 · kind B2 · utility
7Cited by
11References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 9, 2004 |
| Grant date | Mar 9, 2010 |
| Priority date | — |
| Expiry date | Jan 11, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The invention is based on the discovery that compounds of formula (I) possess unexpectedly high affinity for the A2a adenosine receptor, and can be useful as antagonists thereof for preventing and/or treating numerous diseases, including Parkinson's disease. In one embodiment, the invention features a compound of formula I (See formula on paper copy)
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.